PTCT

#1185
PTC Therapeutics, Inc.
73.01 USD
+3.68%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
73.01
73.01
Intervallo Annuale
35.95
87.50
Variazione giornaliera
+3.68%
Variazione Mensile
+12.70%
Variazione di 6 mesi
+10.91%
Variazione Annuale
+63.01%
Chiusura Precedente
70.42
Apertura
73.01
Bid
Ask
Minimo
73.01
High
73.01
Volume
222
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
  • Market Capitalization 6.04 B
  • Employee 991
  • Founded 1998
  • CEO Matthew B. Klein
  • Website www.ptcbio.com
  • Headquarter Delaware, United States
  • FIGI BBG000QT15P7
  • Industry Technology
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
9.76
Rapporto prezzo/fatturato
3.88

PTC Therapeutics Inc

PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control mechanisms in orphan diseases. In September 2009, PTC entered into an agreement with Roche for the development of orally bioavailable small molecules for central nervous system diseases. PTC acquired the Bio-e platform in 2019.

Notizie